Fertility Test in Singapore

At Mediway, Blossom (fertility hormone panel) is $180 for women and $200 for men. Blossom+ (fertility plus pre-conception screen) is $290 for either. Optional AMH add-on is $100. Consultation is optional and not required for testing: book the test online. Each consult is $38 (pre-test or post-results), billed separately. You can choose one or both; to book a consult, WhatsApp us. There is no couples bundle discount, but if both partners test at Mediway, a joint result review can be arranged. All prices are GST-inclusive. Private insurance coverage varies; we provide itemised receipts for submission.

Both include the same fertility hormone panel. Blossom+ adds pre-conception screening: urine, hepatitis, full blood count, blood group, thalassaemia, STI/STD screening, and (for women) rubella immunity. Choose Blossom+ if you are planning to conceive within a year and have not had recent pre-conception screening.

Consider discussing AMH testing with a doctor if you are 35 or older, have irregular cycles, are considering egg freezing, or have a family history of early menopause. AMH can be measured at any point in the menstrual cycle. It gives information about ovarian reserve, but it does not predict pregnancy chances by itself.

A fertility test is a set of blood and (for men) semen tests that look at hormone levels and, for men, semen parameters that may affect the chance of conceiving. For women, it usually includes hormones such as FSH, LH, Estradiol, Prolactin, SHBG, and Progesterone, with optional AMH for ovarian reserve. For men, it typically includes Testosterone, FSH, LH, Prolactin, SHBG, and a semen analysis. A fertility test does not guarantee future pregnancy; it gives information about reproductive health that helps your doctor advise on next steps.

Yes. Male factors can contribute to fertility difficulties, so testing both partners can give a more complete picture. A male fertility test usually includes hormone blood tests (Testosterone, FSH, LH, Prolactin, SHBG) and a semen analysis that looks at sperm count, motility, morphology, and volume. Lifestyle factors, recent illness, medications, and abstinence period can affect results. Your doctor will advise on collection instructions and how to interpret the report.

There is no fixed age, but fertility testing is often considered earlier in the following situations: women under 35 trying to conceive for 12 months without success, women aged 35 or older trying for 6 months without success, irregular or absent periods, known reproductive conditions (such as endometriosis or PCOS), prior pelvic surgery or chemotherapy, or planning ahead (for example, considering egg freezing). Men experiencing difficulty conceiving, low libido, or testicular concerns may also benefit from a fertility test. Earlier review can help identify treatable factors sooner.

Some hormones (FSH, LH, Estradiol) are ideally measured on days 2 to 5 of your cycle for the most interpretable baseline. Progesterone is usually measured around 7 days before your next expected period, often called "day 21" in a 28-day cycle. AMH can be measured at any time. We advise during the consultation. Your results are most useful when timed correctly.

Most fertility blood markers (FSH, LH, Estradiol, Prolactin, Testosterone, AMH) do not require fasting. If additional health-screening tests are included, fasting instructions may differ. Semen analysis does not require fasting, but you may be given separate collection instructions such as an abstinence period before the sample. Confirm during consultation.

Borderline results (mildly elevated prolactin, AMH level lower than expected for age, semen parameters near the lower reference limit) may prompt lifestyle advice, repeat testing, or further evaluation depending on the marker and your history. Clearly abnormal results may be referred to a gynaecologist, fertility specialist, or andrology clinic as appropriate. We provide a clear summary so your specialist has a clear starting point for further evaluation.

Your medical records and results are handled in accordance with Singapore's Personal Data Protection Act (PDPA) and medical confidentiality standards. Fertility results are not shared with a partner or third party without appropriate consent, except where required or permitted by law. For joint reviews, both partners should consent to discussing results together.